BRK-B vs NBTB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NBTB exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and significant valuation upside, trading well below its Graham Number ($52.17) and Intrinsic Value ($98.23). The company demonstrates exceptional growth momentum with 39.5% YoY earnings growth and a stellar 25-quarter track record of meeting or beating estimates. While technical trends are currently bearish (10/100) and insider activity is slightly negative, the fundamental value and growth trajectory strongly outweigh these short-term signals.
Compare Another Pair
Related Comparisons
BRK-B vs NBTB: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and NBT Bancorp Inc. (NBTB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.